Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technivie + Ribavirin in HCV GT4 with Cirrhosis
NCT02265237Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ombitasvir + paritaprevir + ritonavir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Oct 2014; status: completed.
02
Drugs
ombitasvir + paritaprevir + ritonavir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02265237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02265237.